Residiv og overlevelse etter kirurgisk behandling for lungekreft

Tidsskrift for den Norske Laegeforening

Volumn 130, Issue 1, 2010, Pages 25-28

  Hjelde, Harald ^a   Sundstrøm, Stein ^a   Ødegård, Asbjørn ^a   Hatlinghus, Staal ^a   Abusland, Anne Britt ^a   Haaverstad, Rune ^a,b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CARCINOMA; FEMALE; HUMAN; LARGE CELL CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; MORTALITY; NORWAY; PATHOLOGY; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NORWAY; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77449140783     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.09.0689     Document Type: Article

References (18)

1. Number of new cases by primary site and sex - 2007, table 4. Cancer in Norway 2007. Oslo: Kreftregisteret, 2007.
2. Strand TE, Rostad H, Møller B et al. Survival after resection for primary lung cancer: a population-based material of 3,211 resected patients. Thorax 2006; 61: 710-5.
3. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997; 111: 1710-7.
4. Fang D, Zhang D, Huang G et. al. Results of surgical resection of patients with primary lung cancer: a retrospective analysis of 1,905 cases. Ann Thorac Surg 2001; 72: 1155-9.
5. Arriagada R, Bergman B, Dunant A et al. Cisplatinbased adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004; 350: 351-60.
6. Douillard JY, Rosell R, De Lena M et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer. Lancet Oncol 2006; 7: 719-27.
7. Bach, PB, Cramer LD, Shrag DD et al. The infuence of hospital volume on survival after resection for lung cancer. N Engl J Med 2001; 345: 181-8.
8. Bjertnæs AS, Gundersen KH, Nilsen TI et al. Post-operative resultater innen 60 dager ved operativ behandling av ikke-småcellet lungekreft. Kirurgen 2008; 2: 8-11.
9. Modi A, Vohra HA, Weeden DF. Does surgery for primary non-small cell lung cancer and cerebral metastasis have any impact on survival? Interact CardioVasc Thorac Surg 2009; 8: 467-73.
10. Belani CP, Marts S, Schiller J et al. Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical research. Lung Cancer 2007; 55: 15-23.
11. Wynder EL, Muscat JE. The changing epidemiology of smoking and lung cancer histology. Environ Health Perspect 1995; 103 (suppl 8): 143-8.
12. Janssen-Heijnen ML, Coebergh JW. The changing epidemiology of lung cancer in Europe. Lung Cancer 2003; 41: 245-58.
13. Roth K, Nilsen TI, Hatlen E et al. Predictors of long time survival after lung cancer surgery: a retrospective cohort study. BMC Pulm Med 2008; 8: 22.
14. Goldstraw P, Crowley J, Chansky K et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage grouping in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007; 2: 706-14. Erratum: J Thorac Oncol 2007; 2: 985.
15. Kraev A, Rassias D, Vetto J et al. Wedge resection vs lobectomy: 10-year survival in stage I primary lung cancer. Chest 2007; 131: 136-40.
16. Visbal AL, Williams BA, Nichols FC et al. Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002. Ann Thorac Surg 2004; 78: 209-15.
17. Forventet levealder etter land, kjønn og alder. Nordiske land 2005. Statistisk årbok 2006. Oslo: Statistisk sentralbyrå, 2006.
18. Båtevik R, Grong K, Segadal L et al. The female gender has a positive effect on survival independent of background life expectancy following surgical resection of primary non-small cell lung cancer: a study of absolute and relative survival over15 years. Lung Cancer 2005; 47: 173-81.